NCT06887816 Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections
| NCT ID | NCT06887816 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Ortopedico Rizzoli |
| Condition | Hip Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-03-12 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2025-03-12 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the present clinical study, of prospective observational nature with biological study, is to conduct a clinical investigation on the the efficacy of a device coated with bacteriostatic silver coating, with the overall objective of understand whether the device is indeed able to reduce the number of peri-operative and post-operative infections, both early and late.
Eligibility Criteria
Inclusion Criteria: * Patients aged ≥ 18 years; * Immunocompromised patients and/or diabetic patients. * Patients who have given consent Exclusion Criteria: * Patients aged \< 18 years; * Pregnant women;
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06887816 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hip Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06887816 currently recruiting?
Yes, NCT06887816 is actively recruiting participants. Contact the research team at matteo.romagnoli@ior.it for enrollment information.
Where is the NCT06887816 trial being conducted?
This trial is being conducted at Bologna, Italy, Argenta, Italy.
Who is sponsoring the NCT06887816 clinical trial?
NCT06887816 is sponsored by Istituto Ortopedico Rizzoli. The trial plans to enroll 70 participants.